PubMed · 2014 · 14 citations · 34 references
Life SciencesImmunologyOncologyMolecular OncologyNeuroimmunologyTumor ImmunologyImmuno-oncology BiomarkersTumor AntigensTumor ImmunopathologyTumor-associated AntigensClinicopathological CorrelationHumoral Immune Response AlterationsImmunohistochemistry AssaysMage AntigensMelanoma-associated AntigensQuantitative Pcr DetectionTumor Antibody ResponsesTumor Immunogenicity
MAGE-D4 is a novel member of MAGE super-family. It has preliminarily been demonstrated that MAGE-D4 mRNA is not expressed in majority of normal tissues except for brain and ovary in which only trace amount of MAGE-D4 mRNA can be detected, but predominantly expressed in glioma. MAGE-D4 protein expression and its immunogenicity in glioma have not been elucidated well. This study was designed to analyze MAGE-D4 expression both at mRNA and protein level, characteristic of humoral immune response, and their relationships with glioma patients' clinicopathological parameters. Recombinant MAGE-D4 protein and antiserum were generated. Quantitative RT-PCR analysis revealed that MAGE-D4 mRNA expression was overall up-regulated in 41 glioma specimens compared with that in 14 normal brain tissues. Immunohistochemistry analysis showed that 78% (21/27) glioma tissues expressed MAGE-D4 protein, which was predominantly located in the cytoplasm of tumor cells, but absent in any neuroglia cell of normal brain tissues. ELISA analysis demonstrated that humoral response against MAGE-D4 was detected in 17% (7/41) of glioma patients' sera but not in 77 healthy donors. No apparent correlation was observed between the expression and immunogenicity of MAGE-D4 with clinicopathological parameters of glioma. In summary, these results indicate that MAGE-D4 is highly expressed in glioma and can develop specifically humoral response in glioma patients, which supports that it may be a promising biomarker for glioma diagnosis and immunotherapy.
34
Discordant Protein and mRNA Expression in Lung Adenocarcinomas
Guoan Chen, Tarek G. Gharib, Chiang-Ching Huang et al. · Molecular & Cellular Proteomics · 2002 · 948 citations · Full text
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Premal H. Thaker, Michael T. Deavers, Joseph Celestino et al. · Clinical Cancer Research · 2004 · 212 citations
Medicine, Gynecology, Oncology +15
Expression of cancer testis genes in human brain tumors.
Uğur Şahin, Michael Koslowski, Ö. Türeci et al. · PubMed · 2000 · 115 citations
Demethylation of MAGE promoters during gastric cancer progression
T Honda, G Tamura, T. Waki et al. · British Journal of Cancer · 2004 · 91 citations · Full text